Vote in the European Parliament

Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795

Tomislav Sokol – After recital 3 – Am 244
Date: 20.01.2026·Reference: A10-0272/2025
Rapporteur: Tomislav Sokol

Overall Result

Rejected
  • 227 For
  • 299 Against
  • 138 Abstention
  • 55 Did not vote
Amendment— You are viewing a sub-vote (amendment) of the main vote.Amendment 244 · Draft legislative act · Tabled by The LeftView amendment at the EP ↗
Amendment wording

Tabled by Catarina Martins, Anthony Smith

Added: (3 a) Shortages of medicines disproportionately affect women, particularly in areas such as reproductive health, maternal health, menopause treatment, and female cancers. This Regulation should take into account the gender impact and provide for specific measures to address gender inequalities and safeguard equitable access to medicines.

Wording as published by the EP, in English. PE781.998

← Back to Main Vote
Status and procedure

Outcome as recorded by the European Parliament.

Vote held on
Latest recorded step
Committee stage · (122 days ago)
Next scheduled step
Plenary · (in 12 days)

Procedure timeline

2025/0102(COD) · COD

Recorded procedure activities. These do not establish whether a law has entered into force.

  1. Recorded: Referral58 days until the next step
  2. Recorded: Committee stage154 days until the next step
  3. Recorded: Plenary32 days until the next step
  4. Recorded: Negotiations175 days until the next step
  5. Latest recorded: Committee stage122 days since this step began
  6. Planned: Plenary
Recorded activities (25)
  1. Referral to committee
  2. Committee report tabled
  3. Committee amendments tabled
  4. Committee amendments tabled
  5. Committee amendments tabled
  6. Committee opinion adopted
  7. Committee opinion adopted
  8. Committee opinion adopted
  9. Committee report adopted
  10. Tabling for plenary
  11. Tabling for plenary
  12. Tabling for plenary
  13. Tabling for plenary
  14. Tabling for plenary
  15. Tabling for plenary
  16. Tabling for plenary
  17. Plenary debate
  18. Text amended in plenary
  19. Referred back to committee for interinstitutional negotiations
  20. Plenary vote
  21. Plenary vote results
  22. Interinstitutional negotiations
  23. Interinstitutional negotiations
  24. Interinstitutional negotiations
  25. Provisional agreement approved in committee
Scheduled activities (not confirmation of completion)
  1. Plenary debate
  2. Plenary vote
  3. Plenary vote

Procedure file (OEIL) · European Parliament data
Retrieved:

Sources

Data: EP Open Data API

What is this about?

  • This regulation seeks to enhance the security of supply and availability of critical medicines across the EU.
  • It establishes a framework to diversify supply chains and incentivize investments in local manufacturing capacities.
  • Special focus is placed on older, off-patent drugs through targeted financial support and streamlined approval processes.
  • Coordination among member states aims to reduce market fragmentation and strengthen the internal market.
  • The goal is to bolster the EU’s strategic autonomy in the healthcare sector.
Source: Explanatory Statement (AI Generated)

Vote by political group

How the political groups voted

Members

Showing 10 of 719

Vote Position
NameCountryGroupVote Position
GreeceNI
For
ItalyGreens/EFA
For
RomaniaRenew
For
FranceRenew
For
ItalyGUE/NGL
For
BulgariaRenew
For
GreeceS&D
For
NetherlandsRenew
For
DenmarkGreens/EFA
For
SwedenS&D
For
Show more
Follow us on Instagram@checksomevotes@checksomevotes_en